Veterinary Biomarkers Market Size, Share & Trends Analysis Report By Animal Type (Companion Animals, Production Animals), By Product (Biomarker, Kits & Reagents), By Application, By Disease Type, By Region, And Segment Forecasts, 2025 - 2030

Veterinary Biomarkers Market Growth & Trends

The global veterinary biomarkers market size is expected to reach USD 2.14 billion in 2030 and is expected to grow at a CAGR of 12.90% from 2025 to 2030. The key drivers for the market growth are the increasing prevalence of numerous acute and chronic disorders among animals coupled with the growing demand for better & accurate diagnostic and monitoring technologies. According to the American Veterinary Medical Association, almost half of the dog population is developing cancer at the same rate as humans. This supports the requirement for biomarker-based specific diagnostic kits for timely disease predictions and treatments.

The COVID-19 pandemic created barriers and challenges in the global animal health industry that include decreased marketing & sales activities, low veterinary clinic admission, cancellation of routine pet check-ups, and a low number of disease diagnostic tests performed in veterinary hospitals. However, governments and veterinary organizations of various countries implemented strategies and safety measures to resume veterinary practices and research during the pandemic. According to the American Veterinary Medical Association, telemedicine services were widely incorporated in veterinary clinics and hospitals to curb the impact of lockdowns. Furthermore, the pet parents were given digital training to use certain diagnostic kits.

The increasing animal care expenditure in both developing and developed economies is a significant opportunity for market growth. According to the American Kennel Club (AKC), pet owners in the U.S. were spending more money on their pet’s wellness and related healthcare products. The American Pet Products Association reported that the overall pet industry sale exceeded USD 140 billion by the end of 2022. In addition, the research and development activity in the upcoming fields, such as biomarkers in the veterinary, has been significantly growing over the last decade. These factors are expected to boost the growth of the market.

Veterinary Biomarkers Market Report Highlights

• The companion animals segment dominated the industry with the highest revenue share in 2024
• The biomarkers, kits & reagents segment held the largest market share in 2024. This is owing to the wide availability of major brands of biomarkers and test kits launched by key players in the market
• The disease diagnostics segment held the largest market share in 2024
• The inflammatory & infectious diseases segment held the largest market share of 39.34% in 2024
• North America veterinary biomarkers market held a 41.28% share in 2024